Back to results
US 9,789,111 B2Granted
Casein kinase 1δ (CK 1δ) inhibitors
AssigneeElectrophoretics Limited
InventorsJoseph M. Sheridan, Jonathan R. Heal, William D. O. Hamilton, Ian H. Pike
Life of this patent
Estimating the term…
Abstract
The invention relates to pharmaceutical compositions having casein kinase 1 delta (CK1δ) inhibitors and to the use of the inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
Claims8
A method of treating Alzheimer's disease in a subject, comprising:
- administering a therapeutically effective amount of a pharmaceutical composition comprising 5-(1,3-benzoxazol-2-yl)-4-(pyridine-4-yl)pyrimidin-2-amine (Compound 324), or a pharmaceutically acceptable salt or solvate thereof, to the subject;
- and
- treating Alzheimer's disease in the subject.
Dependencies are inferred from the claim text.